IL6 and coronary artery disorder: More precisely, it was found that the Asp358Ala variant in the IL-6 receptor gene, which attenuates IL-6 signaling on hepatocytes, monocytes, and macrophages, was associated with reduced production of CRP and fibrinogen, and subsequently, a reduced risk of CHD [60, 61].